Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock ...

Stock index futures were sharply down on Monday, as risk-off sentiment persisted amid uncertainty regarding President Trump's reciprocal tariffs. S ...

Rithm Property Trust's RPT-C preferred stock offers a 9.875% fixed dividend until 2030, then a floating rate based on SOFR.

FirstEnergy's lackluster dividend growth and limited capital appreciation make it less attractive compared to peers. Find out ...

Case Lake project shows promise with high-grade cesium, lithium, and tantalum mineralization. See why I rate the stock a buy.

PCEPI growing at 4% annualized in Feb 2025 and Core PCEPI at 4.5% annualized. The question is whether this is a blip in ...

Max Helfert is a Master’s in Finance student at USC, pursuing a career in equity research. He specializes in healthcare innovation, leveraging a bottom-up approach to identify high-growth ...

Semrush Holdings basically offers an AI-enhanced SaaS platform for digital marketing. Click here to read why SEMR stock is a ...

Park Ha operates in a large, fast-growing market but faces intense competition and rising costs, impacting profitability. See ...

Puma SE is poised for a turnaround with strong growth plans in the US market and strategic athlete endorsements. Read why ...

Gorman-Rupp has grown its operations. Read why I require confirmation of growth and/or pullback in GRC share price before ...

For Q4 2024, the John Hancock U.S. Growth Fund underperformed the benchmark Russell 1000 Growth Index. Click here to read the ...